SIC
ATRS

Salem Investment Counselors’s Antares Pharma, Inc. ATRS Stock Holding History

Salem Investment Counselors’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-131,120
Closed -$586K – 302
2013
Q4 		$586K Hold
131,120
– – 0.08% 174
2013
Q3 		$532K Hold
131,120
– – 0.07% 184
2013
Q2 		$545K Buy
+131,120
New +$506K 0.08% 172

Other funds holding ATRS

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
WHI
William Harris Investors Chicago, Illinois $347M AUM 3.53% 1-Year Est. Return

Salem Investment Counselors's ATRS Position: Q1 2014 in Review

Salem Investment Counselors sold out of Antares Pharma, Inc. (ATRS) in Q1 2014, closing a stake of 131,120 shares — an estimated $586K sold.

Salem Investment Counselors first reported a position in ATRS in Q2 2013 and held it in 3 quarters. The position peaked at $586K in Q4 2013. 91 funds tracked by Wall St. Rank hold ATRS as of Q1 2014.

  • Salem Investment Counselors reported no remaining Antares Pharma, Inc. position as of Q1 2014 after selling out during the quarter.
  • Salem Investment Counselors sold 131,120 Antares Pharma, Inc. shares in Q1 2014, an estimated $586K.
  • Salem Investment Counselors first reported a position in Antares Pharma, Inc. in Q2 2013 and held it in 3 quarters.
  • Salem Investment Counselors's Antares Pharma, Inc. position peaked at $586K in Q4 2013.
  • 91 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q1 2014.

Based on Salem Investment Counselors's 13F filing for Q1 2014, filed 15 May 2014.